Mendiola, Marta <br/><br/>
Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel.  [electronic resource] 

 -  Oncotarget  Apr 2016 
 - 24217-27 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.8128  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab--administration & dosage<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--blood supply<br/>Female<br/>Follow-Up Studies<br/>Gene Expression Profiling<br/>Humans<br/>Middle Aged<br/>Neovascularization, Pathologic--genetics<br/>Paclitaxel--administration & dosage<br/>Prognosis<br/>Receptor, ErbB-2--metabolism<br/>Survival Rate